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The G-subunit complex derived from heterotrimeric G proteins
can act to regulate the function of a variety of protein targets. We
established lentiviral-based RNA interference in J774A.1 mouse
macrophages to characterize the role of G in G protein-coupled
receptor signaling. The expression of G1 and G2, the major
subtypes present in J774A.1 cells, was eliminated by sequential
treatment with small hairpin RNA expressing lentivirus. These 
complex-deficient cells lost the ability to respond to G protein-
mediated signals. Chemotaxis and the phosphorylation of Akt in
response to C5a were both blocked. Similarly, C5a-mediated actin
polymerization, C5a- and UTP-stimulated intracellular calcium mo-
bilization, and the stimulation of cAMP formation by isoproterenol
were all eliminated in the absence of the G-subunits. In addition,
stabilization and membrane localization of several G- and G-
subunit proteins was strongly effected. Furthermore, in DNA mi-
croarray analysis, regulation of gene expression stimulated by
prostaglandin E2 and UTP was not observed in cells lacking G-
subunits. In contrast, phagocytotic activity, serum-dependent cell
growth and the patterns of gene expression induced by stimulat-
ing the Toll receptors with LPS were similar in wild-type cells and
small hairpin RNA-containing cells. Thus, ablation of the G-
subunits destabilized G- and G-subunits and effectively elimi-
nated G protein-mediated signaling responses. Unrelated ligand
regulated pathways remained intact. These cells provide a system
that can be used to study signaling in the absence of most G
protein-mediated functions.
cell signaling  RNA interference
Upon interaction of G protein-coupled receptors (GPCRs)with their cognate ligands, heterotrimeric G proteins are
activated and dissociate into a GTP-bound -subunit and a 
dimer, and both of these can regulate specific downstream
effector molecules (1, 2). The effector molecules regulated by
G in mammals include certain isoforms of adenylyl cyclase,
phospholipase C- (PLC-), phosphatidylinositol 3-kinase, p21-
activated kinase, and GPCR kinases (3–7). In addition, G has
been shown to modulate the activity of various ion channels (8,
9). The G-subunits are always found in the dimeric form, and
the interaction of the G protein with the G protein appears to
be required for their mutual stability (10). The G-subunit
contains a CAAXmotif at its carboxyl terminus that directs lipid
modification and is required for membrane localization of the
G dimer (11).
The function of the G molecule has mainly been studied in
cell-free systems or on the cellular level. These studies have
helped to define the nature of G interactions with other
molecules (12). A genetic approach to the study of the question
of G function was conducted in Dictyostelium, which contains
a single G-subunit (13). The G-null mutants were severely
defective in development, chemotaxis, and phagocytosis. Ge-
netic analysis has also been useful in establishing some of the
functions of the G1-subunit inCaenorhabditis elegans. Thus, for
example, Zwaal et al. (14) showed that expression of G1 was
important for orientation of the early cell division axis in the first
larval stage. However, it is difficult to study the roles of the G
family members in mammalian systems by using genetic tech-
niques because mammalian cells express multiple G subtypes
that can have similar or overlapping functions (15). However,
gene silencing techniques employing double-stranded small in-
terfering RNA (siRNA) can be used to observe the effects of
specific target protein depletion on cellular function (16, 17).
Furthermore, lentiviral vectors containing a selection marker,
e.g., an antibiotic resistance gene, have been shown to act as
efficient means for delivering siRNA (15, 18). They insert into
the cellular genome and can be used to generate cell lines that
express a specific siRNA as a hairpin structure (shRNA). In the
present study, we demonstrate the effects of eliminating indi-
vidual G isoforms, or all G isoforms, by lentivirus-delivered
shRNAs. We conclude that the G-subunits modulate all of the
GPCR-related cellular responses that we measured. Interest-
ingly, the elimination of a functional G protein-signaling system
leaves other signal transduction pathways intact.
Materials and Methods
Virus Generation. Most lentiviral vectors were constructed and
used for virus generation as described (15, 19). To make
pL-UGIH, puromycin-resistance gene sequences were replaced
with hygromycin-resistance gene sequences in pL-UGIP.
Adenovirus-expressing recombinant Gq proteins were gen-
erated through homologous recombination between a linearized
transfer vector pAD-Track CMV and the adenoviral backbone
vector pAD-easy1 as described (20). The adenoviral vector
contained either the wild-type Gq cDNA (GqW) or the
myristylation mutant Gq cDNA (GqAG) with a Glu-Glu (EE)
epitope in the internal recognition site (171–176 residues) (21).
Expression of recombinant proteins in the virus-infected cells
was verified by immunoblotting with anti-EE antibody (Novus
Biologicals).
Western Blotting. Western blotting was performed with the fol-
lowing antibodies. Anti-phospho Akt antibody (raised against
pSer473-Akt) (Cell Signaling Technology), anti-tubulin antibody
(Oncogene), antibodies for Gi2 and Gq (kind gift from
Susanne Mumby, University of Texas Southwestern Medical
Center, Dallas), anti-G12 antibody (kind gift from Tomiko
Asano, Aichi Human Service Center, Aichi, Japan) (22), anti-
C5a receptor (Pharmingen), and other anti-G protein antibodies
(Santa Cruz Biotechnology) were used to detect their corre-
sponding proteins. Peroxidase-conjugated goat anti-mouse and
anti-rabbit antibodies (Amersham Pharmacia) were used, and
then the proteins were detected by using an enhanced chemilu-
minescence (ECL) reagent (Amersham Pharmacia).
Abbreviations: GPCR, G protein-coupled receptor; PLC, phospholipase C; siRNA, small
interfering RNA; shRNA, small hairpin RNA; PGE2, prostaglandin E2; [Ca2]i, intracellular
Ca2.
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Measurement of Intracellular Ca2 Mobilization and cAMP Assay.
Cells (2  104 per well) were grown in 96-well black wallclear
bottom plates (Corning) overnight. After incubation with 1 M
fura-2AM in Hanks’ balanced salt solution (HBSS) for 30 min,
cells were washed with HBSS twice. The ratio of fluorescence
emission at 510 nm after excitation at 340 nm and 380 nm, caused
by intracellular Ca2 mobilization, was determined by using the
Flexstation, a fluorometric imaging plate reader (Molecular
Devices). cAMP generation was measured by using a HitHunter
cAMP assay kit as described by the manufacturer (Applied
Biosystems).
Chemotaxis and Actin Polymerization. The in vitro cell migration
assay was performed as described (15). J774A.1 cells were plated on
poly{L-lysine)-coated cover slips and incubated overnight in culture
medium.After 6-h serum starvation, cells were stimulatedwithC5a
for 2 min. They were fixed by using 4% paraformaldehyde in PBS
for 30 min. Cells were permeabilized with 0.1% Triton X-100,
stainedwith 0.5 unit of Texas red-conjugated phalloidin (Molecular
Probes), and analyzed by confocal microscopy (Leica).
Cellular Fractionation. Cells were harvested with hypotonic buffer
(20 mM Hepes, pH 7.53 mM MgCl210 mM KCl) containing
protease inhibitors, homogenized by passing through a 26-gauge
needle 10 times. Lysates were centrifuged at 1,000 g for 10 min
to remove unbroken cells and nuclei. The cleared lysates were
subject to ultracentrifugation at 100,000  g for 1 h. The
supernatants were kept as the cytosolic fractions. The precipi-
tates which were kept as the membrane fraction were washed
with same buffer twice and sonicated in a half volume of RIPA
buffer containing protease inhibitors. Thirty micrograms of each
fraction was then loaded on SDSPAGE, followed by Western
blotting with appropriate antibodies.
DNA Microarray. After growth in media containing 0.5% FBS for
18 h, cells were stimulated with agonist for 1 or 4 h, and then
harvested with Trizol (Invitrogen). Total RNAs from the cells
were used for microarray analysis. The 16,000 mouse oligonu-
cleotide arrays were inkjet-printed by Agilent Technologies.
These arrays include 13,536 70mers (Operon Technologies Inc.)
and 2,304 65mers (Sigma-Genosys). The aminoallyl method was
used for the preparation of fluorescently labeled target samples.
All procedures and data analysis methods are described on the
web site of the Alliance for Cellular Signaling (www.signaling-
gateway.orgdataProtocolLinks.html).
Results
Establishment of Cells Lacking G1 and G2 Proteins.Transfection of
J774A.1 cells with plasmid-based expression vectors is very
inefficient (15). However, pseudotyped lentivirus, which effi-
ciently infects these cells and can be integrated into chromo-
somes, is a good carrier for delivery and sustained expression of
genes (18). We constructed lentiviral vectors with cassettes that
allow the expression of GFP and antibiotic selection markers to
identify and enrich the fraction of transduced cells. We have
shown in previous studies that G1 and G2 are the major
abundant G proteins in J774A.1 cells; the other isotypes were
not detected in immunoblot analysis (15). A very low level of
G4 mRNA was found in RT-PCR experiments, but no G4
protein was detected by anti-G4 antibody. To establish cell lines
expressing two siRNA genes, two cycles of infection and selec-
tion were performed. In the first cycle, cells were infected with
a virus containing the G1 shRNA that we previously demon-
strated to be effective (15) and an expression cassette for
puromycin resistance. The cells were then selected by growth in
puromycin. In the second cycle, puromycin-resistant cells were
infected with a virus containing the G2 shRNA expression
construct and a gene expressing hygromycin resistance. They
were then grown and selected with hygromycin. The specific
gene silencing activity of shRNA in the J774A.1 cells was
confirmed by quantitative RT-PCR with specific primers and
immunoblotting for endogenous proteins with isotype-specific
antibodies. The mRNA level of each gene, normalized with
GAPDHmRNA, was decreased by90% in the doubly infected
cells (Fig. 1 A and B). Consistent with RT-PCR data, significant
decreases and inability to detect levels of G1 and G2 proteins
were observed in Western blots (Fig. 1C). Nonetheless, when we
transferred the cells to new plates and cultured at high density,
wild-type and G knockdown cells showed similar growth rates.
At low plating densities the G depleted cells showed slightly
lower viability (data not shown).
Intracellular Ca2 ([Ca2]i) Transients and cAMP Generation Were
Abolished in Cells Depleted of G-Subunits. Increase of cytoplasmic
Ca2 concentration by GPCRs is known to be triggered by at least
two different signaling pathways initiated by components of het-
erotrimeric G proteins, the Gq- and G-subunits. Upon treat-
ment with chemokines or with C5a, G-subunits released from
the GTP-bound forms of Gi increase cytoplasmic Ca2 concen-
tration by activating PLC-2 or PLC-3 (23). C5a-induced [Ca2]i
increases in a pertussis toxin-sensitivemanner (Fig. 2A andprevious
reports). G2 shRNA-containing cells showed a weak response
(peaking at approximately half the level of control cells and of G1
shRNA-containing cells), suggesting that G2 may be the major
transducer of C5a receptor signaling. When we treated G1 and
G2 shRNA-containing cells with C5a, no [Ca2]i release response
was observed (Fig. 2A).
The P2Y receptors, a family of nucleotide receptors, respond to
ligand binding by increasing [Ca2]i release. They are thought to
activate Gq which in turn directly stimulates PLC- activation
(24). Compared with the C5a-dependent [Ca2]i response, UTP, a
ligand interacting with P2Y receptors stimulated more potent and
sustained responses in J774A.1 cells. The [Ca2]i responses were
slightly down-regulated in the cells containing single shRNA di-
rected against G1 alone or against G2 alone. However, cells
Fig. 1. shRNA-mediated inhibition of endogenous G expression in J774A.1
mouse macrophages. (A and B) After lentivirus infection and puromycin
selection for G1 and G2 or two cycles of infection and selection with
puromycin and hygromycin for G1G2, mRNA levels of G-subunits were
analyzed by TaqMan RT-PCR.mRNA levels were normalized to GAPDHmRNA.
(C)Westernblottingusing subtype-specific antibodies. Protein expressionwas
normalized with tubulin levels in total cell extracts.
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depleted of both G1 and G2 by the presence of both shRNAs
showed no detectable [Ca2]i response to UTP exposure (Fig. 2B).
There is a large body of evidence indicating that different 
combinations can substitute for each other in activating PLC (25).
The loss of the [Ca2]i response in doubly depleted cells suggests
that the level of  has been reduced by the absence of both G1
and G2, so that no effective response normally stimulated by a
GPCR through a heterotrimeric complex of  and  can be
mounted. To exclude the possibility that the lack of ligand-
stimulated [Ca2]i release in the absence of Gwas due to shortage
of intracellular Ca2, we evaluated the integrity of the Ca2 stores.
Thapsigargin induced similar [Ca2]i increases in all cell types (data
not shown), indicating that Ca2 stores were not influenced by
shRNA or by absence of G-subunits.
Gs-mediated signaling modulates immune cell responses by
regulating downstream signaling events and chemokine produc-
tion (26, 27). According to gene expression analysis data,
J774A.1 cells express several types of prostaglandin E2 (PGE2)
receptors and 2-adrenergic receptors, which activate Gs (data
not shown). To examine the effect of loss of G on Gs-
mediated signaling, we measured cAMP production stimulated
with PGE2 and isoproterenol. Both agonists induced cAMP
generation in wild-type cells and single shRNA-containing cells,
but not in the cells containing both shRNAs of G1 and G2
(Fig. 2C). On the other hand, forskolin, which directly activates
adenylyl cyclases, induced cAMP production in all cell types.
Taken together, the data suggest that G-subunits are also
essential for Gs-mediated signaling.
Migration Activity Is Impaired in Cells Lacking G Proteins.Migration
of immune cells to most chemokines depends on members of the
pertussis toxin-sensitive Gi signal transducing gene family (28).
The activated receptor releases the G-subunits from the Gi
heterotrimer, and they in turn activate a variety of proteins that are
directly involved in initiating chemotaxis (29). We used Boyden
chamber assays to examine migration activity of the cells to C5a,
whose receptor is expressed in J774A.1. As shown in our previous
report (15), control and G1 shRNA-containing cells migrated to
C5a in a dose-dependent manner. However, manyfold fewer mi-
grating G2 shRNA-expressing cells were observed as a result of
C5a stimulation. For the cells containing both shRNAs that simul-
taneously eliminated G1 and G2, we could not detect any
chemotaxis toward C5a (Fig. 3A). This result further supports the
conclusion that all signaling pathways involved in migration to C5a
were impaired in the absence of G proteins.
Phosphatidyl inositol 3-kinase  (PI3K) plays amajor role in cell
Fig. 3. Effects of G silencing on cell responses to chemokines. (A) Chemo-
taxis of J774A.1 cells toward C5a. Chemotaxis was analyzed by using transwell
migration, as described inMaterials and Methods. The data are expressed as
the mean  SE of three independent experiments. Open square, UGIP (con-
trol); filled circle, G1 shRNA; filled triangle, G2 shRNA; inverted filled
triangle, G1G2 shRNA. (B) C5a-stimulated phosphorylation of Akt. After
incubationwithmedia containing 1% FBS for 12 h, cells were stimulatedwith
C5a for the indicated times. Cell lysates were subjected to immunoblotting
with anti-phospho Akt antibody. Immunoblots were stripped and reprobed
with anti-Akt antibody.
Fig. 2. Ca2 mobilization and cAMP production. Arrows indicate the time
points that stimulantswere added. (A andB) The effect ofG shRNAon [Ca2]i
changes stimulated byGPCR ligands. Cellswere stimulatedwith 20 nMC5a (A)
or 10 M UTP (B), and [Ca2]i was monitored fluorometrically by using
Fura-2AM as described in Materials and Methods. Black, pL-UGIP (control);
red, G1 shRNA; green, G2 shRNA; blue, G1G2 shRNA. (C) cAMP produc-
tion in the cells containing shRNA. Cellswere stimulatedwith 10Mforskolin,
10 M PGE2, or 1 M isoproterenol for 10 min, and cAMP production was
measured as described in Materials and Methods. Relative light units from
experiment were converted to cAMP concentration by using standard curve
per the manufacturer’s description.
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migration by interacting withG-subunits (30, 31). PI3K produces
phosphatidyl inositol-3,4,5-tris-phosphate, which induces mem-
brane translocation and phosphorylation of Akt. We examined Akt
phosphorylation, an event reflective of PI3K activation. The Akt
phosphorylation on Ser-473 by C5a was observed after 2 min of
stimulation and was sustained for 30 min in C5a-treated control
cells and G1 shRNA-containing cells. In G2 shRNA-containing
cells, phosphorylation occurred after 2 min but disappeared within
15 min, implying that G2 is important for extended Akt phos-
phorylation. However, Akt phosphorylation was not detected at all
in the cells containing both shRNAs (Fig. 3B).
C5a Cannot Increase Actin Polymerization in Cells Depleted of G-
Subunits. Polymerization of actin filaments is an indispensable
intracellular event for cell migration in cells responding to chemo-
kines. Rho GTPases are implicated in this process (32). Rho is
implicated in the actin polymerization and formation of focal
adhesion complexes, resulting in actomyosin assembly and the
contractile tension necessary for movement (33). G1213 medi-
ates the Rho activation signal from chemokine receptors by stim-
ulating guanine nucleotide exchange factor, p115Rho-GEF (34).
To determine the effect of G depletion on G1213-mediated
signaling by chemokine receptors, we stimulated the cells with C5a.
Actin polymerization occurred in control cells and single shRNA
containing cells stimulated with uniform C5a for 2 min (Fig. 4).
However, polymerized actin filaments were not observed in cells
containing shRNA directed against both G1 and G2. We ob-
served cells for 30 min in 5-min intervals to exclude delayed
responses to stimulation, but no actin polymerization was detected
(data not shown).
G-Subunits Affected the Expression of G and G. It is well known
that the individual members of the G protein heterotrimers are
necessary for the stability of their binding partners (10, 15).
According to Western blotting and FACS analysis with anti-C5a
receptor antibody, expression levels of the receptor were not
changed in control and shRNA-containing cells, and membrane
localizationwasmaintained (Fig. 5A), indicating that the absence of
Fig. 4. Effects of G silencing on actin polymerization by C5a. Cells were treated with C5a for 2 min, fixed with 4% paraformaldehyde, and stained with Texas
red-conjugated phalloidin. C5a induced actin polymerization in control and the cells containing either G1 or G2 shRNA. However, actin polymerization was
not detected in the cells containing both G1 and G2 shRNA.
Fig. 5. Expression of C5a receptors, G, and G in the absence of G-subunits. (A and B) Cells were lysed with lysis buffer containing 0.1% SDS, and expression
of eachproteinwas analyzedwith specific antibodies. Protein expressionwasnormalized to tubulin levels in total cell extracts. (C) ThedistributionofG-subunits
between cytosol (c) andmembrane (m)was analyzedbyWesternblotting. (D and E) The effect ofmyristylationonexpression and localizationofGq.Adenovirus
containing EE-tagged forms of wild-type Gq and GqAG (myristylation form) were transduced into J774A.1 cells. The cells were harvested, and the expression
of EE-tagged Gq was detected with anti-EE.
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G-subunit proteins does not affect expression of GPCRs. To
examine the stability of G- and G-subunits in the absence of G
subunits, we performed quantitative RT-PCR and Western blot
analysis. The mRNA levels corresponding to all examined proteins
were not affected in the cells depleted of G subunits, compared
with control cells (data not shown). Protein levels ofGi2 andGi3
were not changed significantly, whereas Gq, G12, and G13
were considerably down-regulated in cells lacking G1 and G2
(Fig. 5A). G12 was also down-regulated in the absence of G2
alone. Expression of the G2-, G5-, and G12-subunits was
investigated by using specific antibodies. All G-subunits tested
were significantly diminished in cells depleted of both G1 and
G2, indicating that G affected the generation or stability of
G-subunit protein (Fig. 5B).
Interaction with G-subunits and G lipid modification myri-
stylation and palmitylation are required for the membrane local-
ization of G-subunits (21, 35–37), but there is some controversy
about the relative role of G in the localization of G-subunits.
For example, release of G from the membrane did not prevent
retention of Go in the growth cone of nerve cells (38). Several
G-subunits can be localized in theGolgi membrane in the absence
of G-subunits (39). It has been suggested that double lipid
modification is sufficient to maintain G at the plasma membrane;
however, in the absence of interaction with G-subunits, the G
subunit protein may not be effective. In this study, cells were
separated into cytosol and membrane to identify subcellular local-
ization of G-subunits. As shown in Fig. 5C, the majority of
G-subunits in mock-treated cells were detected in membrane
fractions. In the double knockdown cell, themembrane localization
of Gi2, Gi3, and a portion of the G12 protein was not changed.
On the other hand, a large fraction of the Gq and G13 protein
was absent and residual amounts were detected in the cytosol
fractions of the G-depleted cells. Interestingly, Gi family mem-
bers have dual lipidation (myristylation andpalmitylation), butGq
and G13 lack a myristylation site and have only a palmitylation
residue. To determine the effect of lipid modification on the
expression of G-subunits in the G-deficient cells, we followed
the work of Evanko et al. (21) and constructed recombinant Gq
(GqAG) containing dual lipidation sites by substituting Ala with
Gly in N-terminal region and using an adenoviral vector to mediate
gene expression. After adenovirus infection into control cells and
G-deficient cells, subcellular fractionation was performed. The
expression of GqAG was not changed in both cells, although
wild-type Gq was down-regulated in cells lacking G-subunits
(Fig. 5D). Furthermore, GqAG was detected in the membrane
fraction but not in cytosol fraction, which is similar to its expression
pattern in control cells (Fig. 5E). The results further support the
notion that dual lipid modification, myristylation in addition to
palmitylation, even in the absence of G, is sufficient for mem-
brane localization of the Gq-subunits and perhaps for the Gi-
subunits as well. Once bound to the membrane, the G-subunit
proteins can remain in a stable form. The G-subunits also play
a critical role in stabilizing and directing the singly modified
G-subunits to a suitable membrane region for interaction with the
GPCR (36, 37). The exception not covered by this rule is G12.
Although its level is markedly decreased, the residual protein does
remain associated with the membrane fraction. However, our
fractionation procedure does not allow us to distinguish between
plasma membrane, Golgi, or endoplasmic reticulum. G12 could
interact with other components and be stabilized in the Golgi
fraction.
G-Subunits Were Not Involved in Phagocytotic Activity or Growth of
J774A.1 Cells. In studies of Dictyostelium discoidium, deletion of
G resulted in impaired phagocytosis and chemotaxis (14).
Using opsonized zymosan particles with Ig, we examined phago-
cytotic activity of the cells. Contrary to the results in Dictyoste-
lium, the activity was similar in all cells (data not shown).
Although phagocytosis depends on actin polymerization and
rearrangement, immune cells recognize opsonins such as Ig and
complement that bind to foreign bodies through cognate recep-
tors. These receptors presumably triggered signaling pathways
for phagocytosis without activating heterotrimeric G proteins.
Gene Expression Induced by PGE2 and UTP Was Blocked in the Absence
of G-Subunits.Extracellular stimulants may induce various cellular
responses by regulating specific gene expression. To observe the
effect of the absence of G on ligand-dependent gene regulation,
we examined the gene expression in J774A.1 cells stimulated with
LPS (100 ngml LPS and 100 pM LPS-binding peptide), 10 M
Fig. 6. Hierarchically clustered dendrograms of expression changes induced
by LPS or PGE2. Clustering was achieved by using the CLUSTER and TREEVIEW
programs (http:rana.lbl.govEisenSoftware.htm). Each row represents a
gene, and each column represents a particular sample (1, wild type 1 h; 2, wild
type 4 h; 3, G12 shRNA-harboring cells 1 h; 4, G12 shRNA-harboring
cells 4 h). The expression level for each gene relative to the expression level of
that gene in the 0-h sample was provided by a red–blue color scale shown in
log2 scale. (A) LPS-regulated gene expression changes. Note that the pattern
of regulation observed in wild type was also present in G12 shRNA-
harboring cells. (B) PGE2 regulated gene expression changes. Note that the
regulation observed in wild type was completely absent in G12 shRNA-
harboring cells.
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PGE2, and 10 M UTP by using microarrays that monitored the
expression of 11,000 transcripts. By the criterion of a 2-fold
change in expression in all experiments, exposure of the cells to LPS
for 1 h resulted in the up-regulation of 100 transcripts in control
cells. LPS treatment of cells lacking Gs for 1 h led to a similar
pattern of gene expression as in the control cells. The expression of
200 geneswas changed in response to LPS exposure for 4 h in cells
lacking Gs. Although the overall pattern of gene expression was
similar to that of the control cells, there were subtle differences in
the changes in transcript levels induced byLPS treatment in the cells
lacking G protein (Fig. 6A and data not shown). On the other
hand, PGE2 regulated the expression of 60 genes after 1 h of
treatment and 180 genes after 4 h (Fig. 6B). However, there was no
change in transcript level in the cells depleted ofG-subunits. Thus,
whereas G-subunits are not necessary to mount the Toll receptor
response pattern, the presence of G protein is absolutely required
for the PGE2 response. There is evidence to suggest that some of
the subsequent steps in LPS-stimulated gene expression can be
modulated by GPCR signaling. Thus, for example, PGE2 receptors
are up-regulated by LPS treatment and, when activated, attenuate
LPS-induced gene expression in macrophage cells (26, 40). Ex-
tended treatment with LPS may recruit G protein-signaling path-
ways and modify later gene expression. A more complete analysis
of the effects of the loss of G-subunit protein and the subsequent
interruption of G protein-mediated signaling on ligand induced
responses is required.
Discussion
J774A.1 cells primarily express theG1 andG2 isoforms.Wehave
previously shown that ‘‘knockdown’’ of gene expression of G2 can
lead tomigration defects to some chemokines (15). The loss of both
G1- and G2-subunits leaves the cells with essentially no G.
Because G is stable only in a complex with G, the loss of G
resulted in the collateral loss of the G-subunits. Interestingly the
G-subunit proteins that did not contain multiple lipid modifica-
tion residues and thus did not reach the membrane were also
destabilized. It is not clear whether the membrane-associated
G-subunits have any alternative activity, but it would be surprising
if they could be activated by GPCRs. On the other hand, there
might be other exchange factors that could activate the residual
G-subunits. At present, there is no evidence to support this
conjecture. In fact, all of the data suggest that, although GPCRs
remain intact, the absence of -subunits results in the specific
inactivation of all of the tested G protein gene family-mediated
signaling pathways. The Gs pathway includes gene activation and
cAMP generation by PGE2 and isoproterenol stimulation. TheGi
pathway includes chemotaxis to C5a. The Gq pathway is respon-
sible for Ca2 release in response to UTP, and the G13 pathway
is critical for actin polymerization.
We do not have a comprehensive picture of how the cells adapt
to the absence of the G protein-mediated pathways. However, it
is clear that, when not stressed, they behave relatively normally.
They can grow at rates similar to those of parent cells, can
generate complex responses to ligands such as LPS, and can
organize complex cellular movements and shape changes re-
quired for phagocytosis. On the other hand, the transcriptional
regulation as well as the elevation of cAMP levels mediated by
the application of isoproterenol or PGE2, which utilizes the Gs
pathway, were completely eliminated.
The data with the G1G2 double knockdowns demonstrate
how the individual components of a protein complex can depend
on protein folding and assembly for both their stability and
function. In addition, the data show that, in the absence of a
functioning G protein-mediated signaling system, cells can grow
and other signaling pathways can function. By using a variety of
ligand addition protocols (as described by the Alliance for Cell
Signaling), it may be possible to use the G1G2-depleted cells
in transcript analysis experiments to determine the nature of
signal pathway interaction.
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